Technical Analysis for CRTX - Cortexyme, Inc.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Up | Down | Down |
| Historical CRTX trend table... | |||
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Non-ADX 1,2,3,4 Bearish | Bearish Swing Setup | 0.00% | |
| Bollinger Band Squeeze | Range Contraction | 0.00% | |
| Inside Day | Range Contraction | 0.00% | |
| 20 DMA Resistance | Bearish | -0.11% | |
| 50 DMA Resistance | Bearish | -0.11% | |
| Non-ADX 1,2,3,4 Bearish | Bearish Swing Setup | -0.11% | |
| Bollinger Band Squeeze | Range Contraction | -0.11% | |
| Outside Day | Range Expansion | -0.11% | |
| 50 DMA Resistance | Bearish | -3.13% | |
| Non-ADX 1,2,3,4 Bearish | Bearish Swing Setup | -3.13% |
Free Daily (Stock) Chart Reading
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: ???
- Sector: Healthcare
- Industry: Biotechnology
Cortexyme is a clinical stage pharmaceutical company pioneering a novel disease-modifying therapeutic approach to treat a key underlying cause of Alzheimer's disease and other degenerative diseases. Cortexyme is targeting a specific, infectious pathogen found in the brain of Alzheimer’s patients and tied to neurodegeneration and neuroinflammation in animal models. The company's lead investigational medicine, COR388, is the subject of the GAIN Trial, an ongoing Phase 2/3 clinical study in patients with mild to moderate Alzheimer’s.
Medical Specialties Organ Systems Alzheimer's Disease Nervous System Degenerative Diseases Neurology Stage Pharmaceutical
Medical Specialties Organ Systems Alzheimer's Disease Nervous System Degenerative Diseases Neurology Stage Pharmaceutical
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 73.84 |
| 52 Week Low | 19.35 |
| Average Volume | 170,335 |
| 200-Day Moving Average | 41.51 |
| 50-Day Moving Average | 47.56 |
| 20-Day Moving Average | 47.93 |
| 10-Day Moving Average | 46.36 |
| Average True Range | 3.00 |
| ADX | 10.36 |
| +DI | 14.04 |
| -DI | 17.99 |
| Chandelier Exit (Long, 3 ATRs ) | 43.66 |
| Chandelier Exit (Short, 3 ATRs ) | 52.34 |
| Upper Bollinger Band | 52.35 |
| Lower Bollinger Band | 43.51 |
| Percent B (%b) | 0.25 |
| BandWidth | 18.44 |
| MACD Line | -0.31 |
| MACD Signal Line | -0.02 |
| MACD Histogram | -0.2872 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 48.46 | ||||
| Resistance 3 (R3) | 48.56 | 47.74 | 48.01 | ||
| Resistance 2 (R2) | 47.74 | 47.05 | 47.70 | 47.86 | |
| Resistance 1 (R1) | 46.75 | 46.62 | 46.34 | 46.65 | 47.71 |
| Pivot Point | 45.93 | 45.93 | 45.73 | 45.89 | 45.93 |
| Support 1 (S1) | 44.94 | 45.24 | 44.53 | 44.85 | 43.79 |
| Support 2 (S2) | 44.12 | 44.81 | 44.08 | 43.64 | |
| Support 3 (S3) | 43.13 | 44.12 | 43.49 | ||
| Support 4 (S4) | 43.04 |
